Libra Therapeutics Launches with $29 Million Series A to Develop Novel Therapeutics for Neurodegenerative Diseases
Amount Raised
$29 Million
Round Type
Series A
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Libra Therapeutics, Inc. launched today to develop novel drug candidates focused on restoring the cellular balance lost in neurodegenerative diseases. These include amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), which are both characterized by disequilibrium caused by the production and decreased clearance of neurotoxic proteins. In conjunction with the company’s launch, Libra Therapeutics has secured $29 million in Series A financing co-led by Boehringer Ingelheim Venture Fund (BIVF), Epidarex Capital, and Santé
Quick answer
Libra Therapeutics raised $29 Million in a Series A round, dated September 23, 2020. Libra Therapeutics is based in San Diego, California, United States.
- How much did Libra Therapeutics raise?
- Libra Therapeutics raised $29 Million in a Series A round on September 23, 2020.
- What does Libra Therapeutics do?
- Libra Therapeutics is a biotechnology company developing novel disease-modifying therapeutics to restore disrupted cellular balance in lysosome function and autophagy with the potential to slow the disease progression..
- Where is Libra Therapeutics based and how big is it?
- Libra Therapeutics is based in San Diego, California, United States. Fundz records about 6 employees.
- Who are the decision-makers at Libra Therapeutics?
- Fundz holds 1 contact at Libra Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Libra Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Viridian Therapeutics raised $91M on November 6, 2020.
- Damora Therapeutics, Inc. raised $64M on November 5, 2020.
- Strata Oncology raised $5M on November 4, 2020.
- Lipella Pharmaceuticals raised $405K (Seed) on November 4, 2020.
- AbSci Corp raised $65M on October 30, 2020.
- Q32 Bio raised $60M (Series B) on October 29, 2020.
Who to call at Libra Therapeutics, and when
A new round usually means Libra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Libra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Libra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Libra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Libra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLibra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.